Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

EU Commission proposes extending vaccine export-control scheme

Published 09/27/2021, 05:55 AM
Updated 09/27/2021, 06:01 AM
© Reuters.

© Reuters.

BRUSSELS (Reuters) - The European Commission has proposed extending the period of its scheme for monitoring and potentially limiting exports of COVID-19 vaccines from the bloc, a European Commission spokesperson told Reuters on Monday.

If not prolonged, the scheme would expire this week. It is unclear whether the 27 EU states will support the proposal, which requires a qualified majority to be adopted.

"Discussions are ongoing with member states, so we cannot comment further," the spokesperson said. If extended, the scheme would remain in place until the end of the year.

The scheme has already been extended twice after its initial launch at the end of January, despite criticism from some smaller states that feared it was not necessary and could damage the bloc's competitiveness.

Under EU rules, the Commission could appeal against a possible rejection by EU governments.

The EU Commission established the mechanism amid the bloc's vaccine supply crisis and in a bid to curb exports by pharmaceutical companies deemed not to be respecting their commitments with the EU.

© Reuters. FILE PHOTO: Vials labelled

The mechanism has, however, allowed the export of hundreds of millions of shots made in the EU towards dozens of countries around the world.

It has been formally used to block only one shipment of 250,000 AstraZeneca (NASDAQ:AZN) doses to Australia in March, after the Anglo-Swedish firm cut supplies to the EU.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.